Education
About Us
Working with TipRanks
Follow Us
FLGB - ETF AI Analysis
Top Page
Franklin FTSE United Kingdom ETF (FLGB)
Rating:72Outperform
Price Target:―
Positive Factors
Low Expense Ratio
The fund charges a relatively low fee, which helps investors keep more of their returns over time.
Broad Sector Diversification Within the UK
Holdings spread across financials, consumer goods, industrials, health care, energy, and other sectors help reduce the impact of weakness in any single industry.
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Negative Factors
Heavy UK Concentration
Almost all assets are invested in UK companies, so the fund is highly sensitive to the health of the UK economy and market.
Top Holdings Concentration
A small number of large positions like HSBC, AstraZeneca, and Shell make up a significant share of the portfolio, increasing the impact if any of these stocks struggle.
Mixed Performance Among Key Stocks
Some major holdings such as AstraZeneca, Shell, Unilever, and GSK have shown weaker year-to-date performance, which can drag on overall fund returns even as others perform well.
FLGB vs. SPDR S&P 500 ETF (SPY)
AUM881.10M
RegionEurope
Expense Ratio0.09%
Beta0.58
IssuerFranklin
Inception DateNov 02, 2017
Dividend Yield3.37%
Asset ClassEquity
Index TrackedFTSE UK RIC Capped Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume615,198
30 Day Avg. Volume266,990
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
39.19Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering94
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FLGB Summary
The Franklin FTSE United Kingdom ETF (FLGB) tracks the FTSE UK RIC Capped Index, giving you broad exposure to the overall UK stock market in a single investment. It holds many well-known British companies such as HSBC Holdings and AstraZeneca, along with banks, consumer brands, energy firms, and industrial companies. Someone might consider this ETF to diversify outside their home country and to invest in the long-term growth of the UK economy without picking individual stocks. A key risk is that its value can rise or fall with the UK stock market and the health of the UK economy.
How much will it cost me?The Franklin FTSE United Kingdom ETF (FLGB) has an expense ratio of 0.09%, which means you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, keeping costs down.
What would affect this ETF?The Franklin FTSE United Kingdom ETF (FLGB) could benefit from positive trends in the UK economy, such as growth in the financial and healthcare sectors, which are heavily weighted in the fund. However, potential risks include economic uncertainty due to interest rate changes, energy price volatility affecting holdings like Shell and BP, and regulatory shifts impacting major industries like financials and consumer goods. Investors should also consider how broader European economic conditions might influence the ETF's performance.
FLGB Top 10 Holdings
FLGB leans heavily on a handful of UK blue chips, with health care and financials setting the tone. AstraZeneca and GSK are doing the heavy lifting, rising steadily and giving the fund a solid defensive backbone. HSBC is another key engine, with strong recent momentum helping drive overall returns. On the consumer side, Unilever is climbing but feels a bit like it’s running with a parachute, as sentiment is still mixed. Energy names like Shell and BP are contributing steadily, making this a firmly UK-focused play with limited tech exposure and plenty of old-economy muscle.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| HSBC Holdings | 8.89% | $77.16M | £218.61B | 50.15% | 80 Outperform | |
| AstraZeneca | 8.83% | $76.66M | $300.81B | 24.33% | 80 Outperform | |
| Shell (UK) | 7.63% | $66.22M | £182.70B | 26.30% | 73 Outperform | |
| Rolls-Royce Holdings | 4.49% | $38.94M | £109.48B | 71.27% | 71 Outperform | |
| Unilever | 4.23% | $36.70M | £105.90B | ― | 72 Outperform | |
| British American Tobacco | 3.78% | $32.79M | £94.69B | 37.57% | 71 Outperform | |
| GlaxoSmithKline | 3.36% | $29.14M | £82.75B | 38.66% | 77 Outperform | |
| BP p.l.c. | 3.28% | $28.46M | £79.00B | 23.28% | 71 Outperform | |
| Rio Tinto | 2.85% | $24.77M | £116.00B | 44.78% | 82 Outperform | |
| BAE Systems | 2.72% | $23.64M | £64.95B | 40.78% | 61 Neutral |
FLGB Technical Analysis
Neutral
―
Price Trends
35.38
Negative
33.90
Positive
32.31
Positive
Market Momentum
-0.02
Positive
43.33
Neutral
29.55
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FLGB, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 36.18, equal to the 50-day MA of 35.38, and equal to the 200-day MA of 32.31, indicating a neutral trend. The MACD of -0.02 indicates Positive momentum. The RSI at 43.33 is Neutral, neither overbought nor oversold. The STOCH value of 29.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FLGB.
FLGB Peer Comparison
Comparison Results
Performance Comparison
FLGB
Franklin FTSE United Kingdom ETF
34.98
7.60
27.76%
EWU
iShares MSCI United Kingdom ETF
―
―
―
SPEU
SPDR Portfolio Europe ETF
―
―
―
DBEU
Xtrackers MSCI Europe Hedged Equity ETF
―
―
―
FKU
First Trust United Kingdom AlphaDEX Fund
―
―
―
EWUS
iShares MSCI United Kingdom Small Cap ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents